RE: Why you lot9 May 2020 14:47
Soup just to clarify that wasn’t my point I wasn’t saying he lied about the dismissal that hadn’t happened!
On the 24th of December he did a podcast to say payment was fine and it’s because they are working on a better deal..
On feb 5th they RNS’d this
On 30 October 2019 Nuformix received confirmation in writing from NSB of an acceptable solution to resolving the outstanding £2.5m payment due
· During face-to-face meetings with NSB senior management in Shanghai on 4th -8th November 2019, Nuformix Chairman, Dave Tapolczay, was given further verbal assurances of payment by 15 November 2019
· Nuformix was then told that payment was delayed due to an on-going audit of NSB and its parent company, Zheiiang Yatai Pharmaceutical, but that payment would be made once the audit completed (forecasted end November)
· Nuformix noted an announcement by Zheiiang Yatai Pharmaceutical on 23 January 2020 confirming the dismissal of the Group's primary contact at Newsummit Biopharma
So that says to me what he said in December podcast was BS as the RNS clearly states they were having problems in China (if I owe you £100 and I keep telling you yes I’ll give it you after the 3rd 4th 5th time you know I have no intention would you then say oh it’s ok because brooko is gonna give me more....)
There is a chance your man in China was leading them down a garden path which is why he got the sack however as a ceo to be fooled like that again is unacceptable.
Now the situation will be they have to write the deal off or start legal proceedings which will have to be funded by raising funds imo loose loose situation!
I was not here at any point saying that the fundamentals are no good however the ceo has made some costly mistakes and I can’t see how they finalise a deal for 002 after this carry on!
Good luck all
Sign In
Follow the stocks
